556 related articles for article (PubMed ID: 24857747)
1. Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis.
Diolaiti D; McFerrin L; Carroll PA; Eisenman RN
Biochim Biophys Acta; 2015 May; 1849(5):484-500. PubMed ID: 24857747
[TBL] [Abstract][Full Text] [Related]
2. The Mlx network: evidence for a parallel Max-like transcriptional network that regulates energy metabolism.
Billin AN; Ayer DE
Curr Top Microbiol Immunol; 2006; 302():255-78. PubMed ID: 16620032
[TBL] [Abstract][Full Text] [Related]
3. Normal and Neoplastic Growth Suppression by the Extended Myc Network.
Prochownik EV; Wang H
Cells; 2022 Feb; 11(4):. PubMed ID: 35203395
[TBL] [Abstract][Full Text] [Related]
4. The MNT transcription factor autoregulates its expression and supports proliferation in MYC-associated factor X (MAX)-deficient cells.
Lafita-Navarro MC; Liaño-Pons J; Quintanilla A; Varela I; Blanco R; Ourique F; Bretones G; Aresti J; Molina E; Carroll P; Hurlin P; Romero OA; Sanchez-Céspedes M; Eisenman RN; Delgado MD; León J
J Biol Chem; 2020 Feb; 295(7):2001-2017. PubMed ID: 31919096
[TBL] [Abstract][Full Text] [Related]
5. Of Myc and Mnt.
Hooker CW; Hurlin PJ
J Cell Sci; 2006 Jan; 119(Pt 2):208-16. PubMed ID: 16410546
[TBL] [Abstract][Full Text] [Related]
6. The MYCL and MXD1 transcription factors regulate the fitness of murine dendritic cells.
Anderson DA; Murphy TL; Eisenman RN; Murphy KM
Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4885-4893. PubMed ID: 32071205
[TBL] [Abstract][Full Text] [Related]
7. The activities of MYC, MNT and the MAX-interactome in lymphocyte proliferation and oncogenesis.
Link JM; Hurlin PJ
Biochim Biophys Acta; 2015 May; 1849(5):554-62. PubMed ID: 24731854
[TBL] [Abstract][Full Text] [Related]
8. The non-enzymatic RAS effector RASSF7 inhibits oncogenic c-Myc function.
Kumaraswamy A; Mamidi A; Desai P; Sivagnanam A; Perumalsamy LR; Ramakrishnan C; Gromiha M; Rajalingam K; Mahalingam S
J Biol Chem; 2018 Oct; 293(40):15691-15705. PubMed ID: 30139745
[No Abstract] [Full Text] [Related]
9. MondoA, a novel basic helix-loop-helix-leucine zipper transcriptional activator that constitutes a positive branch of a max-like network.
Billin AN; Eilers AL; Coulter KL; Logan JS; Ayer DE
Mol Cell Biol; 2000 Dec; 20(23):8845-54. PubMed ID: 11073985
[TBL] [Abstract][Full Text] [Related]
10. Coordinated Cross-Talk Between the Myc and Mlx Networks in Liver Regeneration and Neoplasia.
Wang H; Lu J; Alencastro F; Roberts A; Fiedor J; Carroll P; Eisenman RN; Ranganathan S; Torbenson M; Duncan AW; Prochownik EV
Cell Mol Gastroenterol Hepatol; 2022; 13(6):1785-1804. PubMed ID: 35259493
[TBL] [Abstract][Full Text] [Related]
11. The Mad side of the Max network: antagonizing the function of Myc and more.
Rottmann S; Lüscher B
Curr Top Microbiol Immunol; 2006; 302():63-122. PubMed ID: 16620026
[TBL] [Abstract][Full Text] [Related]
12. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation.
Lüscher B; Larsson LG
Oncogene; 1999 May; 18(19):2955-66. PubMed ID: 10378692
[TBL] [Abstract][Full Text] [Related]
13. Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis.
Carroll PA; Diolaiti D; McFerrin L; Gu H; Djukovic D; Du J; Cheng PF; Anderson S; Ulrich M; Hurley JB; Raftery D; Ayer DE; Eisenman RN
Cancer Cell; 2015 Feb; 27(2):271-85. PubMed ID: 25640402
[TBL] [Abstract][Full Text] [Related]
14. Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas.
Schaub FX; Dhankani V; Berger AC; Trivedi M; Richardson AB; Shaw R; Zhao W; Zhang X; Ventura A; Liu Y; Ayer DE; Hurlin PJ; Cherniack AD; Eisenman RN; Bernard B; Grandori C;
Cell Syst; 2018 Mar; 6(3):282-300.e2. PubMed ID: 29596783
[TBL] [Abstract][Full Text] [Related]
15. The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis.
Carroll PA; Freie BW; Mathsyaraja H; Eisenman RN
Front Med; 2018 Aug; 12(4):412-425. PubMed ID: 30054853
[TBL] [Abstract][Full Text] [Related]
16. Drosophila Myc: A master regulator of cellular performance.
Grifoni D; Bellosta P
Biochim Biophys Acta; 2015 May; 1849(5):570-81. PubMed ID: 25010747
[TBL] [Abstract][Full Text] [Related]
17. Stabilization of the Max Homodimer with a Small Molecule Attenuates Myc-Driven Transcription.
Struntz NB; Chen A; Deutzmann A; Wilson RM; Stefan E; Evans HL; Ramirez MA; Liang T; Caballero F; Wildschut MHE; Neel DV; Freeman DB; Pop MS; McConkey M; Muller S; Curtin BH; Tseng H; Frombach KR; Butty VL; Levine SS; Feau C; Elmiligy S; Hong JA; Lewis TA; Vetere A; Clemons PA; Malstrom SE; Ebert BL; Lin CY; Felsher DW; Koehler AN
Cell Chem Biol; 2019 May; 26(5):711-723.e14. PubMed ID: 30880155
[TBL] [Abstract][Full Text] [Related]
18. Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation.
Hurlin PJ; Quéva C; Koskinen PJ; Steingrímsson E; Ayer DE; Copeland NG; Jenkins NA; Eisenman RN
EMBO J; 1995 Nov; 14(22):5646-59. PubMed ID: 8521822
[TBL] [Abstract][Full Text] [Related]
19. MAX mutant small-cell lung cancers exhibit impaired activities of MGA-dependent noncanonical polycomb repressive complex.
Llabata P; Torres-Diz M; Gomez A; Tomas-Daza L; Romero OA; Grego-Bessa J; Llinas-Arias P; Valencia A; Esteller M; Javierre BM; Zhang X; Sanchez-Cespedes M
Proc Natl Acad Sci U S A; 2021 Sep; 118(37):. PubMed ID: 34493659
[TBL] [Abstract][Full Text] [Related]
20. Demystifying the Druggability of the MYC Family of Oncogenes.
Karadkhelkar NM; Lin M; Eubanks LM; Janda KD
J Am Chem Soc; 2023 Feb; 145(6):3259-3269. PubMed ID: 36734615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
